“american-diabetes-association” Archives

in
Entry Author Date Location
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later 11/29/18 San Diego
MR3 Health Takes Aim at Foot Ulcers as San Antonio Tackles Diabetes 10/30/18 Texas
Senators Grill HHS’s Azar on Drug Price Cuts That Have Yet to Come 06/26/18 National
Amid Focus On Value, Forward Health Group’s Software Gets Qualified 03/21/17 Wisconsin
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
NephroGenex Aims to Raise $7.5M for Diabetic Nephropathy Drug 07/17/15 Raleigh Durham
NephroGenex Preps $30M Stock Offering to Expand Kidney Drug Trial 05/01/15 Raleigh Durham
Vascular Pharmaceuticals Lands $9M For Diabetes Drug Trials 03/03/15 Raleigh Durham
Forward Health Stays Aggressive in Healthcare Analytics, Snags $5.7M 01/15/15 Wisconsin
West Coast Biotech Roundup: Burrill, Topol, Aduro, Receptos, & More 06/19/14 San Francisco
Metabolic Solutions Announces New Findings in Diabetes Treatment 06/12/12 Detroit Ann Arbor
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News 06/30/11 San Diego
A San Diego Sampler from the War on Diabetes 06/24/11 San Diego
Calibra, Inspired by Inventor With Diabetes, Homes in on Cheap, Easy Way to Deliver Insulin 01/24/11 San Francisco
Hygieia Progressing with Software and Device to Guide Insulin Dosages for Diabetics 01/03/11 Detroit Ann Arbor
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients 11/09/10 San Diego
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Tethys Snags $33M in Equity, Debt for Predictive Diabetes Test 07/21/10 San Francisco
Orexigen Drug Shows Potential as “Two-Fer” Against Obesity and Diabetes 06/25/10 San Diego
Amylin’s Would-Be Savior, Once-Weekly Diabetes Shot, Shows Two-Year Benefit 06/07/09 San Diego
Arena Obesity Drug Helps Patients Shed a Few Pounds, Lower Risk of Heart Disease 06/06/09 San Diego
Orexigen Obesity Drug Produces “Modest” Weight Loss, Lowers Cardiovascular Risk 06/06/09 San Diego
Page 1 of 1